Improving prostate cancer risk assessment using advanced 3D imaging techniques
Prostate cancer risk stratification via computational 3D pathology
This study is looking at new 3D imaging techniques to better understand prostate cancer from biopsy and surgery samples, so doctors can more accurately tell which patients have low-risk versus high-risk cancer and provide more personalized treatment options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10877958 on NIH RePORTER |
What this research studies
This research focuses on enhancing the management of prostate cancer by utilizing advanced 3D imaging technologies to analyze biopsy and surgical specimens. Traditional methods rely on 2D histology, which can lead to subjective interpretations and misclassification of cancer severity. By employing open-top light-sheet microscopy, the study aims to provide a more accurate and comprehensive assessment of prostate cancer, allowing for better differentiation between low-risk and high-risk patients. This innovative approach seeks to improve patient stratification for treatment options, potentially leading to more personalized care.
Who could benefit from this research
Good fit: Ideal candidates for this research include men diagnosed with prostate cancer who are undergoing biopsy or surgical treatment.
Not a fit: Patients with non-prostate cancer conditions or those who have already received definitive treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate risk stratification for prostate cancer patients, improving treatment decisions and outcomes.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques for cancer diagnosis, indicating potential success for this novel approach.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Liu, Jonathan T.c. — University of Washington
- Study coordinator: Liu, Jonathan T.c.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.